Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
How do you decide the threshold and duration of subretinal fluid that can be safely tolerated in exudative AMD when adjusting treat-and-extend intervals?
Related Questions
What has been your experience incorporating the Port Delivery System (PDS) into clinical practice?
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
How do you decide which secondary IOL to place in an aphakic eye?
What techniques do you use to minimize the risk of buckle extrusion or infection, especially in younger or highly myopic patients?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
How has using a chandelier for scleral buckling impacted your teaching or surgical outcomes?
In which cases of post-injection endophthalmitis should early vitrectomy be considered if there is little to no improvement 48 hours after a tap and inject and there is no organism isolated?
How would you manage a patient who develops a 1 mm abscess at the internal os of the paracentesis tract following an AC tap after an Izervay injection with eye pain but no vitreous cell or retinal involvement?
What clinical and diagnostic factors best predict who will benefit from intervention versus observation for patients with visually significant floaters?
What guides reoperation versus observation in managing macular folds after retinal detachment surgery?
